[March 05, 2013]

Research and Markets: Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013 Provides Briefing Pertaining To the Number of Trials for the Key Drugs

Research and Markets (http://www.researchandmarkets.com/research/6rsctt/diabetic) has announced the addition of GlobalData's new report "Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013" to their offering.

The clinical trial report, Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical tials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Gastroparesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-Pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Companies Mentioned:

Tranzyme Pharma, Inc.

GlaxoSmithKline plc

Rhythm Pharmaceuticals

Evoke Pharma, Inc.

Aptalis Pharma SAS (News - Alert)

UCB S.A.

Malmo University Hospital

Yokohama City University

Osaka City University

Mayo Clinic

Shaare Zedek Medical Center

Rabin Medical Center

For more information visit http://www.researchandmarkets.com/research/6rsctt/diabetic

Source (News - Alert): GlobalData

[ Back To Technology News's Homepage ]